TACI Peptide
Product Specifications
NCBI Gene ID
23495
Swiss Prot
O14836
Accession Number
NP_036584
Type
Peptides
Concentration
200 ug/mL
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Shipping Conditions
Blue Ice
Storage Conditions
Store TACI peptide at -20˚ C, stable for one year.
Applications Notes
TACI peptide is used for blocking the activity of TACI antibody.
NCBI Official Name
Tumor necrosis factor receptor superfamily, member 13B
NCBI Organism
Homo sapiens
Background Reference 01
Von Bulow GU, Bram RJ. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science. 1997;278 (5335) :138-41.
Background Reference 02
Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100 (5) :575-85.
Background Reference 03
Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol. 2000;165 (6) :2937-42.
Other Product Names
CVID, RYZN, TACI, CD267, CVID2, TNFRSF14B, Tumor necrosis factor receptor superfamily member 13B, Transmembrane activator and CAML interactor
Tested Applications
Blocking
Species
Human
Protein ID
6912694
Physical Properties
Liquid
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS257169-20ug 20 µg
C9orf43 (NM_152786) Human Over-expression Lysate
Sign In for Pricing
View Details 
433694-01 100 mg
4,5-Dihydro-1-[3- (trifluoromethyl) phenyl]-1H-pyrazol-3-amine Hydrochloride
Sign In for Pricing
View Details